October 24, 2022

Biotalys and Novozymes announce successful Evoca™ feasibility study

PDF icon
EN PDF icon
NL
September 13, 2022

Biotalys announces participation at investor and industry events for the upcoming months

PDF icon
EN PDF icon
NL
August 19, 2022

Biotalys Reports Half-Year 2022 Financial Results and Business Highlights

PDF icon
EN PDF icon
NL
July 29, 2022

Information on the total number of voting rights and shares

PDF icon
EN PDF icon
NL
June 21, 2022

Biotalys and Novozymes Enter into Partnership to Expand Opportunities for Evoca™

PDF icon
EN PDF icon
NL
May 25, 2022

Biotalys’ First Biocontrol Evoca Wins World BioProtection Award 2022 for Best Biofungicide Product

PDF icon
EN PDF icon
NL
May 19, 2022

Latest Field Trials Validate Strength of Biotalys’ First Biocontrol Evoca 

PDF icon
EN PDF icon
NL
May 3, 2022

Biotalys Obtains New Fungicide Resistance Class for its First Biofungicide

PDF icon
EN PDF icon
NL
April 29, 2022

Information on the total number of voting rights and shares

PDF icon
EN PDF icon
NL
April 18, 2022

Biotalys Appoints Michiel van Lookeren Campagne to Board of Directors

PDF icon
EN PDF icon
NL
April 15, 2022

Results of the Annual and Extraordinary Shareholders’ Meetings

PDF icon
EN PDF icon
NL
March 31, 2022

Biotalys Appoints Carlo Boutton as Chief Scientific Officer

PDF icon
EN PDF icon
NL
March 15, 2022

Invitation to the Annual and Extraordinary Shareholders’ Meetings

PDF icon
EN PDF icon
NL
March 11, 2022

Biotalys Reports Full Year 2021 Financial Results and Business Highlights

PDF icon
EN PDF icon
NL
February 15, 2022

Notice of Full Year 2021 Results and Business Highlights

PDF icon
EN PDF icon
NL